Abstract
D’Amico et al. show that, in the presence of oncogenic RAS mutations, STAT3 acts as a tumour modifier by regulating the epithelial differentiation of pancreatic and lung cancer cells via p63.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have